Navigation Links
Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis
Date:10/16/2010

EAST HANOVER, N.J., Oct. 16 /PRNewswire/ -- Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast® (zoledronic acid) injection in postmenopausal women with osteoporosis.(1) The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada.

The study showed that Reclast maintained bone mass in postmenopausal osteoporotic patients who received annual infusions for six years.(1) In patients who stopped Reclast treatment after three years, the bone mineral density (BMD) decreased significantly but remained well above the levels measured at the beginning of the study (difference between the two groups at six years: 1.04%, p-value = 0.0009).(1)

Patients who stayed on Reclast therapy for six years reduced their risk of new morphometric spine fractures by 52%, compared to those who stopped treatment at three years (p-value = 0.04).(1) Morphometric fractures can occur unaccompanied by pain and therefore may not be diagnosed and treated; they can be felt or seen over time in the form of back pain, loss of height, or stooped posture.(4)

"These new findings show that continued treatment with zoledronic acid for six years continues to maintain bone mass and reduce vertebral fractures risk with no change to its favorable safety profile compared to discontinuation of treatment after three years," said Dennis Black, PhD, the study's lead author and Professor of Epidemiology and Biostatistics at the University of California, San Francisco.  "These new long-term data reconfirm Reclast as an important therapeutic option for doctors when considering osteoporosis treatment for their patients."

In both study groups, the bone markers were maintained over six years within the normal premenopausal range.(1) In patients who discontinued Reclast after three years, there was no evid
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
2. Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management
3. NCPA Announces New Division Dedicated to Long-Term Care Pharmacies, Patients
4. Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy
5. Long-Term Data Show Advantages for TAXUS® Liberte® Stent in Small Vessels and Long Lesions
6. New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years
7. Study of Long-Term Efficacy and Safety of New PyratineXR™ Moisturizing Lotion Featured in Journal of Drugs in Dermatology
8. Partnership for Quality Medical Donations Commits to Long-Term Recovery in Haiti
9. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
10. FIRMAGON® Results in Fast, Long-Term Suppression of Testosterone in Prostate Cancer Patients Without Initial Testosterone Surge
11. FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Thoratec Corporation (NASDAQ: THOR ), ... to save, support and restore failing hearts, said today ... Global Healthcare Conference on Wednesday, September 10. ... Officer, will provide an update on the company, beginning ... Daylight Time).   A webcast of the ...
(Date:8/29/2014)... 2014 Research and Markets  has announced the ... 2014" report to their offering. The ... of the largest segments of pharmaceuticals industry. The numbers of ... available therapies were unable to meet the market requirements. There ... CNS disorder, especially over the past two decades. The market ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation ... U.S. District Court for the District of ... in the company,s case against Sandoz, Inc. regarding United ... Peter Sheridan ruled that U.S. Patent No. 6,765,117 ... enjoined Sandoz from marketing its generic product until the ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2
(Date:9/1/2014)... "Women struggle with weight gain typically associated to ... early as 15, if not earlier. Women therefore ... downs of hormone related weight gain. The battle ... to rage against the hidden and ever-present hormones which ... begin to face menopause and related changes, these hormonal ...
(Date:9/1/2014)... September 01, 2014 As well as ... Derek is currently pursuing counselor certification in Louisiana. ... through the CPI training program as well as the ... have grown both personally and professionally. I am ... am competently able to do so. As a ...
(Date:9/1/2014)... Parties involved in federally-filed Tylenol lawsuits ... status conference in September, where issues related to claims ... Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. ... on the Court’s website, the meeting is scheduled to ... This is the latest of several Tylenol conferences that ...
(Date:9/1/2014)... 01, 2014 The Outlier Series announced ... exclusive interview content from one of the exceptional women ... Outliers: Women Game Changers . The title of the ... Game Changer Jenny McClendon . McClendon is currently a ... formerly the star of WeTV show, Raising Sextuplets. , ...
(Date:9/1/2014)... September 01, 2014 Psychogenic Non-epileptic Seizures ... a psychological disorder that can have devastating effects on ... like epileptic seizures however, they are not produced by ... triggers. It is estimated that the numbers of ... by multiple sclerosis. , Dr. Lorna Myers, ...
Breaking Medicine News(10 mins):Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:The Northeast Regional Epilepsy Group (NEREG) Offers First Conference on Psychogenic Non-epileptic Seizures (PNES) on September 20, 2014 in New Jersey 2
... molecular mechanisms associated with the development and progression of ... The research, published by Cell Press in the January ... may lead to development of future strategies for treatment ... are derived from migratory neural crest cells that give ...
... January 5, 2008 Scientists from the Gladstone ... discovered that a certain type of collagen, collagen VI, ... widely thought to cause Alzheimer,s disease (AD). While the ... established, before this study it was unknown that collagen ...
... Oral-B Partner with Operation Smile to See the Difference, ... From January through March 2009, Crest and Oral-B are encouraging people ... own smile while also making a difference in children,s smiles worldwide. ... see the difference in their smile. People can also ...
... of infamous psychological obedience study in 1960s , , MONDAY, ... as willing to follow orders to hurt others as they ... , In a replication of one of the most famous ... give what they believed were increasingly painful electric shocks to ...
... Disability healthcare reform will be the subject of ... Disability (NCD) on Tuesday, January 13, 2009, from 3:00 ... held at the Chaparral Suites Resort, 5001 N. Scottsdale ... public. The forum will explore the relationship between health ...
... retinal cell gets infected with the common cytomegalovirus, contiguous ... may provide clues to better treatment of this potentially ... provide new insight into the larger issue of how ... a disease process such as diabetes, said Dr. Sally ...
Cached Medicine News:Health News:New insight into aggressive childhood cancer 2Health News:Collagen VI may help protect the brain against Alzheimer's disease 2Health News:Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Children's Smiles Around the World 2Health News:Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Children's Smiles Around the World 3Health News:Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Children's Smiles Around the World 4Health News:Researcher Finds Most Will Inflict Pain on Others If Prodded 2Health News:Researcher Finds Most Will Inflict Pain on Others If Prodded 3Health News:Disability Healthcare Policy Forum to Be Held in Scottsdale, Arizona 2Health News:Cell death from cytomegalovirus may bring new life to treatment of retinal disease 2
2.5mm...
... 12 bevel tip; silicone sleeve ... is opposite curve, Designed for ... Sleeve acts as stop & ... chance of trauma to the ...
Stab incision blades color coded for simple and accurate identification...
Formed 12.0mm from bend to tip; radius is 12.5 mm;, Curved sharp cutting edge requires less pressure to cut the capsule, reducing stress to zonules. 1.5mm long x .75 mm wide...
Medicine Products: